|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-1-22
|
|
pubmed:abstractText |
Adeno-associated viral (AAV) and lentiviral vectors are promising vectors for gene therapy for hemophilia because they are devoid of viral genes and have the potential for long-term gene expression.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1538-7933
|
|
pubmed:author |
pubmed-author:Acosta-SanchezAA,
pubmed-author:ChuahM K LMK,
pubmed-author:CollenDD,
pubmed-author:DE WaeleLL,
pubmed-author:GillijnsVV,
pubmed-author:IwasakiYY,
pubmed-author:NICC,
pubmed-author:PetrusII,
pubmed-author:ThorrezLL,
pubmed-author:VandendriesscheTT,
pubmed-author:WangLL,
pubmed-author:WilsonJ MJM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
16-24
|
|
pubmed:meshHeading |
pubmed-meshheading:17002653-Animals,
pubmed-meshheading:17002653-Bleeding Time,
pubmed-meshheading:17002653-Dependovirus,
pubmed-meshheading:17002653-Factor IX,
pubmed-meshheading:17002653-Gene Therapy,
pubmed-meshheading:17002653-Genetic Vectors,
pubmed-meshheading:17002653-Heart Diseases,
pubmed-meshheading:17002653-Hemophilia B,
pubmed-meshheading:17002653-Lentivirus,
pubmed-meshheading:17002653-Liver,
pubmed-meshheading:17002653-Male,
pubmed-meshheading:17002653-Mice,
pubmed-meshheading:17002653-Mice, Inbred C57BL,
pubmed-meshheading:17002653-Mice, Nude,
pubmed-meshheading:17002653-Mice, SCID,
pubmed-meshheading:17002653-Mice, Transgenic,
pubmed-meshheading:17002653-Myocardium,
pubmed-meshheading:17002653-Serotyping,
pubmed-meshheading:17002653-Time Factors,
pubmed-meshheading:17002653-Transduction, Genetic,
pubmed-meshheading:17002653-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy.
|
|
pubmed:affiliation |
Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
